FDA 483 - Curia New Mexico, LLC - June 28, 2024

An FDA inspection of Curia New Mexico, LLC, a sterile drug manufacturer in Albuquerque, NM, revealed significant deficiencies in aseptic processing. Observations included unvalidated hold times for environmental monitoring samples, a lack of required testing for Grade A filling lines, and improper personnel monitoring procedures, indicating potential risks to product sterility.